Germany’s BioNTech buys China’s Biotheus in US$800 million push into cancer drugs

SCMP | Nov. 13, 2024, 10:52 p.m. | Original
BioNTech says deal will support its push into the development of cancer drugs using its proven mRNA technology.
Can Hongkongers make it big in Peru? The country’s Chinese community, experts weigh in New York City bans practice forcing tenants pay property brokers hired by landlords